Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 1
2015 1
2016 2
2017 1
2020 4
2021 4
2022 5
2023 7
2024 9
2025 6
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.
Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters KB, Clarke J, Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F, Umemura Y, Nabors B, Holdhoff M, Hottinger AF, Arakawa Y, Sepulveda JM, Wick W, Soffietti R, Perry JR, Giglio P, de la Fuente M, Maher EA, Schoenfeld S, Zhao D, Pandya SS, Steelman L, Hassan I, Wen PY, Cloughesy TF; INDIGO Trial Investigators. Mellinghoff IK, et al. N Engl J Med. 2023 Aug 17;389(7):589-601. doi: 10.1056/NEJMoa2304194. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272516 Free PMC article. Clinical Trial.
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419).
Hertler C, Felsberg J, Gramatzki D, Le Rhun E, Clarke J, Soffietti R, Wick W, Chinot O, Ducray F, Roth P, McDonald K, Hau P, Hottinger AF, Reijneveld J, Schnell O, Marosi C, Glantz M, Darlix A, Lombardi G, Krex D, Glas M, Reardon DA, van den Bent M, Lefranc F, Herrlinger U, Razis E, Carpentier AF, Phillips S, Rudà R, Wick A, Tabouret E, Meyronet D, Maurage CA, Rushing E, Rapkins R, Bumes E, Hegi M, Weyerbrock A, Aregawi D, Gonzalez-Gomez C, Pellerino A, Klein M, Preusser M, Bendszus M, Golfinopoulos V, von Deimling A, Gorlia T, Wen PY, Reifenberger G, Weller M. Hertler C, et al. Among authors: bumes e. Eur J Cancer. 2023 Aug;189:112913. doi: 10.1016/j.ejca.2023.05.002. Epub 2023 May 8. Eur J Cancer. 2023. PMID: 37277265 Free article.
Temporal Muscle Thickness as a Prognostic Marker in a Real-Life Cohort of Newly Diagnosed MGMT Promoter Methylated Glioblastoma: A Multicentric Imaging Analysis.
Lazaridis L, Moenninghoff C, Bumes E, Spille DC, Müther M, Schulz T, Heider S, Agkatsev S, Schmidt T, Blau T, Oster C, Stummer W, Kessler AF, Seidel C, Grauer O, Hau P, Ahmadipour Y, Sure U, Keyvani K, Herrlinger U, Kleinschnitz C, Stuschke M, Guberina N, Herrmann K, Deuschl C, Scheffler B, Kebir S, Glas M. Lazaridis L, et al. Among authors: bumes e. Cancer Med. 2025 Apr;14(8):e70689. doi: 10.1002/cam4.70689. Cancer Med. 2025. PMID: 40260649 Free PMC article.
Benchmarking palliative care practices in neurooncology: a german perspective.
Lawson McLean AC, Lawson McLean A, Ernst T, Forster MT, Freyschlag C, Gempt J, Goldbrunner R, Grau S, Jungk C, van Oorschot B, Rosahl SK, Wedding U, Senft C, Kamp MA; German Consortium for Excellence in Neurooncology, Palliative Care (GCE-NPC). Lawson McLean AC, et al. J Neurooncol. 2024 Jun;168(2):333-343. doi: 10.1007/s11060-024-04674-7. Epub 2024 May 2. J Neurooncol. 2024. PMID: 38696050 Free PMC article.
Psycho-oncological burden in patients with brain metastases undergoing neurological surgery.
Araceli T, Fischl A, Haj A, Doenitz C, Stoerr EM, Hillberg A, Vogelhuber M, Rosengarth K, Riemenschneider MJ, Hau P, Blazquez R, Pukrop T, Bumes E, Schmidt NO, Proescholdt M. Araceli T, et al. Among authors: bumes e. Front Oncol. 2024 Nov 28;14:1463467. doi: 10.3389/fonc.2024.1463467. eCollection 2024. Front Oncol. 2024. PMID: 39669367 Free PMC article.
MRI-defined patterns of infiltration and outcome in patients with glioblastoma.
Scheu K, Vandieken E, Hense K, Rosengarth K, Haedenkamp T, Lenglinger M, Bumes E, Linker R, Proescholdt M, Schmidt NO, Riemenschneider MJ, Wendl C, Wiesinger I, Hau P. Scheu K, et al. Among authors: bumes e. Neurooncol Adv. 2025 Jul 11;7(1):vdaf114. doi: 10.1093/noajnl/vdaf114. eCollection 2025 Jan-Dec. Neurooncol Adv. 2025. PMID: 40842643 Free PMC article.
36 results